Does the presence of ductal adenocarcinoma change how you risk stratify or treat patients with localized prostate cancer?
How would it change your risk group or management? Does Decipher help further inform treatment?
Answer from: Medical Oncologist at Community Practice
Ductal adenocarcinoma (DAC) of the prostate is a distinct, but rare (< 1%) subtype of prostate adenocarcinoma. DAC originates from primary periurethral prostatic ducts or in the peripheral prostatic ducts. Because of its predominantly periurethral location, it may present with hematuria, urgency,...
Comments
Radiation Oncologist at LJA Please see my article on our experience at Columbi...
Radiation Oncologist at Multicare Radiation Therapy @Gene, I've read your paper. I should note that Ji...
Radiation Oncologist at LJA @Robert,
thank you! And back then, we were taught...
Please see my article on our experience at Columbi...
@Gene, I've read your paper. I should note that Ji...
@Robert, thank you! And back then, we were taught...